Skip to main content
Premium Trial:

Request an Annual Quote

Sankyo Pharma Taps Gentris for Pharmacogenomics Diagnostics

NEW YORK, Feb. 24 - Gentris, a North Carolina clinical pharmacogenomics company, said today that it has begun a three-year non-exclusive collaboration with Sankyo Pharma, the US subsidiary of Japanese pharmaceutical firm Sankyo Co., Ltd.


The companies will partner on a pharmacogenomic test panel based on proprietary tests developed by Gentris to investigate drug pharmacokinetics, pharmacodynamics, safety, and efficacy.  


In addition, Gentris and Sankyo Pharma said they would work jointly on new diagnostic tests to complement Sankyo's new drugs.

The Scan

Researchers Develop Polygenic Risk Scores for Dozens of Disease-Related Exposures

With genetic data from two large population cohorts and summary statistics from prior genome-wide association studies, researchers came up with 27 exposure polygenic risk scores in the American Journal of Human Genetics.

US Survey Data Suggests Ancestry Testing Leads Way in Awareness, Use of Genetic Testing Awareness

Although roughly three-quarters of surveyed individuals in a Genetics in Medicine study reported awareness of genetic testing, use of such tests was lower and varied with income, ancestry, and disease history.

Coral Genome Leads to Alternative Amino Acid Pathway Found in Other Non-Model Animals

An alternative cysteine biosynthesis pathway unearthed in the Acropora loripes genome subsequently turned up in sequences from non-mammalian, -nematode, or -arthropod animals, researchers report in Science Advances.

Mosquitos Genetically Modified to Prevent Malaria Spread

A gene drive approach could be used to render mosquitos unable to spread malaria, researchers report in Science Advances.